|Go to calendar|
|Title:||How can Cambridge create more discovery start-ups?|
|When:||18.07.2012 17:30 - 20:30|
|Location:||Deloitte LLP, City House, 126-130 Hills Road, Cambridge. CB2 1RY|
|Description:||The context for choosing this slightly parochial topic is a perceived, by some, slipping of the Cambridge cluster’s edge as the jewel in the UK crown when it comes to the pipeline of biotech companies being started. It wasn’t long ago that nobody questioned Cambridge as the leading biotech hub in Europe, but of late it would appear other regions may be gaining and even surpassing Cambridge in creating new discovery companies.|
On a global basis, it will remain in most minds that Cambridge is the ‘UK leader’ for some time, not least due to the name and brand with its subconscious alignment with Cambridge MA. It is vital that Cambridge (UK) continues to deliver since it is taken as a (bio)marker of UK strength in biotech and we don’t wish to see that diminished from a UK plc perspective in the minds of overseas investors and companies.
We are seeing some good companies started, such as Discuva, Convergence and Crescendo, but what more needs to be done to maintain a healthy mix of discovery, solution provider and CRO companies in the sector?
17.30 - Registration and Networking
18.30 – Welcome from the Host, Stuart Henderson, Deloitte
18.35 – Introduction from the Chair, Rowan Gardner, Chairman, BioLauncher
18.40 – ‘Beyond Discovery’ - New Models of How to Build Lasting Value from Spin-Outs,
TranScrip Parters tbc
18.55 – Panel Debate: How Can Cambridge Create More Discovery Start-ups?
Dr Anthony Baxter, CEO, Cyprotex
Dr Keith Powell, Chairman, Domainex
Dr Sunil Shah, Director, Piramal Development Solutions
19.40 - Closing Remarks from the Chair
19.45 - Thanks from One Nucleus
19.50 - Networking over Drinks and Canapés
21.00 - Close
Gold Members 3 free delegates then £40.00+VAT for additional delegates
Silver Member 3 free delegates then £40.00+VAT for additional delegates
|Copy:||Copy to my calendar|